retatrutide weight loss efficacy Eli Lilly's shows promising results in phase 3 trial Phase III retatrutide study demonstrates

Proper injection technique, site rotation, and allowing the medication to reach room temperature before injection (if recommended in your product's IFU) can minimize these effects

Muscle pain and body aches Muscle pain and general body aches occur in some patients, particularly during early treatment or after dose escalation

In a long-term evaluation of the LEADER trial with 9,340 patients with T2D over a 3.5- to 5-year period, there was no evidence of C-cell malignancies occurred in the liraglutide group [84]

29, 2025 (GLOBE NEWSWIRE) -- This industry analysis defines "best" based on public visibility, consumer interest signals, and availability of verifiable company disclosures, not medical efficacy